Tech Company Financing Transactions

InSilico Medicine Funding Round

InSilico Medicine closed a $60 million Series D investment round on 6/6/2022. Investors included B Capital Group, Bold Capital Partners and Pavilion Capital Partners.

Transaction Overview

Company Name
Announced On
6/6/2022
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series D
Proceeds Purpose
Capital raised in the round will further bolster Insilico's financial position and fuel the growth of its advancing pipeline, including its lead program which is currently in a Phase I study, and continued development of its Pharma.AI platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Core Building 1 1 Science Park East Ave.Hong Kong Science Pa 307A
Hong Kong, 00000
Hong Kong
Phone
Undisclosed
Email Address
Overview
Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research. We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions.
Profile
InSilico Medicine LinkedIn Company Profile
Social Media
InSilico Medicine Company Twitter Account
Company News
InSilico Medicine News
Facebook
InSilico Medicine on Facebook
YouTube
InSilico Medicine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alex Zhavoronkov
  Alex Zhavoronkov LinkedIn Profile  Alex Zhavoronkov Twitter Account  Alex Zhavoronkov News  Alex Zhavoronkov on Facebook
Chief Operating Officer
Qingsong Zhu
  Qingsong Zhu LinkedIn Profile  Qingsong Zhu Twitter Account  Qingsong Zhu News  Qingsong Zhu on Facebook
Chief Scientific Officer
Jimmy Lin
  Jimmy Lin LinkedIn Profile  Jimmy Lin Twitter Account  Jimmy Lin News  Jimmy Lin on Facebook
Chief Technical Officer
Alex Zhebrak
  Alex Zhebrak LinkedIn Profile  Alex Zhebrak Twitter Account  Alex Zhebrak News  Alex Zhebrak on Facebook
President
Alex Aliper
  Alex Aliper LinkedIn Profile  Alex Aliper Twitter Account  Alex Aliper News  Alex Aliper on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/6/2022: Magical venture capital transaction
Next: 6/6/2022: Souq G-Commerce venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary